Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SCLX |
---|---|---|
09:32 ET | 3640 | 1.62 |
09:34 ET | 10890 | 1.6175 |
09:36 ET | 7091 | 1.625 |
09:38 ET | 100 | 1.625 |
09:39 ET | 1837 | 1.625 |
09:43 ET | 4750 | 1.64 |
09:45 ET | 4708 | 1.6302 |
09:48 ET | 1930 | 1.6309 |
09:50 ET | 17050 | 1.6183 |
09:52 ET | 1850 | 1.59 |
09:57 ET | 718 | 1.59 |
10:01 ET | 1522 | 1.595 |
10:03 ET | 940 | 1.6 |
10:06 ET | 1000 | 1.6 |
10:08 ET | 100 | 1.595 |
10:10 ET | 126 | 1.595 |
10:12 ET | 376 | 1.5999 |
10:14 ET | 1199 | 1.6 |
10:15 ET | 100 | 1.59 |
10:17 ET | 7515 | 1.595 |
10:19 ET | 4200 | 1.61 |
10:21 ET | 56202 | 1.65 |
10:24 ET | 1470 | 1.6492 |
10:26 ET | 1320 | 1.645 |
10:28 ET | 348 | 1.645 |
10:32 ET | 1890 | 1.645 |
10:35 ET | 11999 | 1.65 |
10:37 ET | 1067 | 1.65 |
10:44 ET | 200 | 1.65 |
10:46 ET | 200 | 1.6478 |
10:48 ET | 500 | 1.645 |
10:50 ET | 48813 | 1.68 |
10:51 ET | 19390 | 1.695 |
10:53 ET | 42373 | 1.675 |
10:55 ET | 2523 | 1.67 |
10:57 ET | 7336 | 1.655 |
11:00 ET | 320 | 1.6501 |
11:02 ET | 2200 | 1.6502 |
11:06 ET | 800 | 1.66 |
11:09 ET | 200 | 1.66 |
11:18 ET | 1200 | 1.655 |
11:26 ET | 223 | 1.6599 |
11:29 ET | 200 | 1.66 |
11:38 ET | 500 | 1.655 |
11:47 ET | 923 | 1.66 |
11:49 ET | 600 | 1.665 |
11:51 ET | 1000 | 1.665 |
12:00 ET | 450 | 1.6699 |
12:02 ET | 893 | 1.66 |
12:07 ET | 1176 | 1.675 |
12:16 ET | 400 | 1.68 |
12:18 ET | 100 | 1.69 |
12:21 ET | 2083 | 1.6987 |
12:23 ET | 14267 | 1.68 |
12:25 ET | 500 | 1.685 |
12:27 ET | 750 | 1.68 |
12:30 ET | 305 | 1.685 |
12:32 ET | 200 | 1.68 |
12:34 ET | 4589 | 1.67 |
12:38 ET | 3955 | 1.67 |
12:43 ET | 100 | 1.66 |
12:57 ET | 200 | 1.665 |
12:59 ET | 190 | 1.665 |
01:01 ET | 6815 | 1.66 |
01:06 ET | 2300 | 1.66 |
01:10 ET | 200 | 1.67 |
01:12 ET | 6898 | 1.655 |
01:15 ET | 200 | 1.6515 |
01:17 ET | 450 | 1.6508 |
01:21 ET | 400 | 1.65 |
01:28 ET | 100 | 1.655 |
01:32 ET | 100 | 1.65 |
01:35 ET | 1497 | 1.65 |
01:37 ET | 7000 | 1.64 |
01:39 ET | 400 | 1.635 |
01:42 ET | 101 | 1.635 |
01:48 ET | 100 | 1.635 |
01:55 ET | 300 | 1.635 |
01:57 ET | 583 | 1.634 |
02:00 ET | 100 | 1.635 |
02:02 ET | 100 | 1.635 |
02:04 ET | 13752 | 1.63 |
02:06 ET | 100 | 1.63 |
02:08 ET | 500 | 1.6211 |
02:09 ET | 1928 | 1.6352 |
02:11 ET | 505 | 1.6392 |
02:13 ET | 1100 | 1.63 |
02:15 ET | 5400 | 1.635 |
02:18 ET | 104 | 1.635 |
02:20 ET | 5898 | 1.6254 |
02:22 ET | 12206 | 1.615 |
02:27 ET | 1006 | 1.615 |
02:29 ET | 200 | 1.615 |
02:31 ET | 108 | 1.615 |
02:33 ET | 333 | 1.615 |
02:36 ET | 1860 | 1.615 |
02:38 ET | 308 | 1.61 |
02:42 ET | 1006 | 1.615 |
02:45 ET | 100 | 1.62 |
02:47 ET | 112 | 1.615 |
02:49 ET | 2481 | 1.62 |
02:51 ET | 511 | 1.63 |
02:54 ET | 600 | 1.625 |
02:58 ET | 1909 | 1.625 |
03:00 ET | 300 | 1.625 |
03:02 ET | 2947 | 1.625 |
03:03 ET | 2001 | 1.625 |
03:05 ET | 6524 | 1.615 |
03:07 ET | 603 | 1.615 |
03:09 ET | 300 | 1.615 |
03:12 ET | 1176 | 1.615 |
03:14 ET | 700 | 1.61 |
03:16 ET | 6710 | 1.605 |
03:18 ET | 1259 | 1.605 |
03:20 ET | 1497 | 1.6 |
03:21 ET | 2538 | 1.6099 |
03:23 ET | 762 | 1.6 |
03:25 ET | 2969 | 1.6 |
03:27 ET | 1343 | 1.6 |
03:30 ET | 4462 | 1.6 |
03:32 ET | 1456 | 1.6 |
03:34 ET | 600 | 1.6 |
03:36 ET | 1200 | 1.6 |
03:38 ET | 1781 | 1.6 |
03:39 ET | 900 | 1.6 |
03:41 ET | 28665 | 1.59 |
03:43 ET | 1762 | 1.59 |
03:45 ET | 1391 | 1.591 |
03:48 ET | 1059 | 1.59 |
03:50 ET | 3255 | 1.595 |
03:52 ET | 2489 | 1.59 |
03:54 ET | 24064 | 1.59 |
03:56 ET | 10663 | 1.59 |
03:57 ET | 7356 | 1.59 |
03:59 ET | 79165 | 1.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Scilex Holding Co | 264.2M | -1.3x | --- |
Elite Pharmaceuticals Inc | 157.1M | 10.1x | --- |
Zevra Therapeutics Inc | 240.6M | -5.0x | --- |
Eton Pharmaceuticals Inc | 96.3M | -96.4x | --- |
CorMedix Inc | 233.1M | -4.6x | --- |
Dbv Technologies SA | 139.0M | -2.0x | --- |
Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. Its second commercial product ELYXYB, is a potential first-line treatment, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. Its product candidates include SP-102 (SEMDEXA), SP-103 and SP-104. SP-102 is a viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica. Its SP-103 is a triple-strength formulation of ZTlido, for the treatment of chronic neck pain.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $264.2M |
---|---|
Revenue (TTM) | $46.7M |
Shares Outstanding | 166.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.25 |
Book Value | $-1.73 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -225.55% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.